|
MCL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.316400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.671040E-01 |
| Normal-vs-Stage2 |
3.303200E-01 |
| Normal-vs-Stage3 |
5.692400E-02 |
| Normal-vs-Stage4 |
2.807000E-01 |
| Stage1-vs-Stage2 |
8.862200E-01 |
| Stage1-vs-Stage3 |
1.537190E-01 |
| Stage1-vs-Stage4 |
5.991200E-01 |
| Stage2-vs-Stage3 |
2.114000E-01 |
| Stage2-vs-Stage4 |
4.943400E-01 |
| Stage3-vs-Stage4 |
8.225800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.606600E-01 |
| Normal-vs-AfricanAmerican |
2.082000E-01 |
| Normal-vs-Asian |
1.578190E-02 |
| Caucasian-vs-AfricanAmerican |
6.941200E-01 |
| Caucasian-vs-Asian |
3.684300E-02 |
| AfricanAmerican-vs-Asian |
3.197000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.620630E-01 |
| Normal-vs-Female |
5.495000E-01 |
| Male-vs-Female |
1.190230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.692000E-02 |
| Normal-vs-Extreme_Weight |
2.262200E-01 |
| Normal-vs-Obese |
4.505400E-01 |
| Normal-vs-Extreme_Obese |
8.286100E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.878200E-01 |
| Normal_Weight-vs-Obese |
9.478000E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.461200E-01 |
| Extreme_Weight-vs-Obese |
5.787400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.515800E-01 |
| Obese-vs-Extreme_Obese |
2.303400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.542800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.741800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.254990E-01 |
| Normal-vs-Age(81-100Yrs) |
1.089600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.433600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.548300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.501500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.725040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.152430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.609800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.424000E-01 |
| Normal-VS-Type2 PRCC |
3.227900E-02 |
| Normal-VS-KIRP CIMP |
8.867600E-01 |
| Normal-VS-Unclassified PRCC |
1.132000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.424000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.006200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.689700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.677800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.141400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.462100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.984300E-02 |
| Normal-vs-N1 |
3.481600E-01 |
| Normal-vs-N2 |
5.679800E-01 |
| N0-vs-N1 |
1.145780E-01 |
| N0-vs-N2 |
6.861400E-03 |
| N1-vs-N2 |
1.650400E-01 |
|
|
